Published February 21, 2018
| Version v1
Dataset
Open
The process of HDAC11 Assay Development: using kit
Description
Preliminary tests to check if the Fluor-de-Lys-green HDAC activity kit could be used for developing a high-throughput HDAC11 assay have been performed here using controls and recombinantly purified HDAC11.
Notes
The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.
Files
21feb2018-HDAC11 assay deve process-kit.pdf
Files
(204.3 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:4bf1fecc09ae3848ae191dc2cdbf056c
|
204.3 kB | Preview Download |